Curiteva, Inc.
PrivateLast Round
Seed Round
Jan 5, 2024
Total Funding Raised
$20.5M
Company Overview
Curiteva, Inc. is a medical device and technology company that manufactures and commercializes spinal implant systems to advance spine surgery and improve clinical outcomes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, 3D Printing, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curiteva, Inc. Comparables
Compare Curiteva, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 4WEB Medical | 90% | |
| NanoHive Medical | 89% | |
| Camber Spine Technologies | 88% | |
Curiteva, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jan 5, 2024 | ||||
| Series A | Dec 3, 2020 |
Curiteva, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eastside Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 192% MoM, reaching 5.3K.
- Mar 31, 2026
Developing Inspire, the world's first 3D-Printed Trabecular PEEK.
Curiteva, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Curiteva, Inc.'s valuation, stock price, and market status.